SpringWorks Therapeutics

General Information
Business:

 

We are a clinical-stage biopharmaceutical company applying a precision medicine approach to acquiring, developing and commercializing life-changing medicines for underserved patient populations suffering from devastating rare diseases and cancer. We have a differentiated portfolio of small molecule targeted oncology product candidates and are advancing two potentially registrational clinical trials in rare tumor types, as well as several other programs addressing highly prevalent, genetically defined cancers.

Industry: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES)
Employees: 52
Founded: 2017
Contact Information
Address 100 Washington Blvd., Stamford, CT 06902, US
Phone Number (203) 883-9490
Web Address http://www.springworkstx.com
View Prospectus: SpringWorks Therapeutics
Financial Information
Market Cap $753.9mil
Revenues $0 mil (last 12 months)
Net Income $-36.5 mil (last 12 months)
IPO Profile
Symbol SWTX
Exchange NASDAQ
Shares (millions): 9.0
Price range $18.00 - $18.00
Est. $ Volume $162.0 mil
Manager / Joint Managers ​J.P. Morgan/ Goldman Sachs/ Cowen​ ​
CO-Managers Wedbush PacGrow
Expected To Trade: 9/13/2019
Status: Priced
Quiet Period Expiration Date:
Lock-Up Period Expiration Date:
SCOOP Rating
Rating Change